Windlas Biotech Buyback 2026
Windlas Biotech Limited bought back up to 4,70,000 shares at ₹1,000 each (₹47 crore) through a tender offer. The record date was 24 Apr 2026.
Windlas Biotech Buyback Dates
- 17 Apr 2026 Board approval · Buyback approved
- 18 Apr 2026 Public announcement · Terms announced
- 24 Apr 2026 Record date · Buy by 23 Apr to qualify
- 28 Apr 2026 Letter of offer · Sent with your entitlement
- 30 Apr 2026 Tender opens · Place tender orders
- 7 May 2026 Tender closes · Last day to tender
- 14 May 2026 Payment · Paid; unaccepted shares returned
- 25 May 2026 Shares extinguished · Buyback complete
Windlas Biotech Buyback Details
Windlas Biotech Buyback Tendered Shares
From the stock exchanges' acquisition window, as of 7 May 2026, 4:00 PM. Bids are the same on NSE and BSE; the exchanges don't split them into the small-shareholder and general categories — the registrar does that after the close.
Windlas Biotech Buyback Acceptance Ratio
Share of tendered shares the company bought, from the post-offer public announcement.
Check Windlas Biotech Buyback Status
The registrar confirms how many of your tendered shares were accepted; payment and the return of unaccepted shares follow by 14 May 2026.
Windlas Biotech Buyback Calculator
Enter your holding to see your category, the shares you are entitled to tender and what they come to after tax. An illustration of the offer terms, not advice.
How the Windlas Biotech Buyback Is Taxed
Taxed as capital gains. Only your gain (buyback price minus what you paid) is taxed, as a capital gain: 12.5% if you held the shares for more than 12 months (above the ₹1.25 lakh yearly exemption), 20% if you held them for 12 months or less. Promoters pay an additional tax.
Shares that are not accepted stay in your demat account; nothing is taxed on them until you sell.
Small Shareholder or General Category?
You are a small shareholder if your Windlas Biotech shares are worth no more than ₹2 lakh at the closing price on the record date. At least 15% of the buyback is reserved for small shareholders (97,342 shares here), and they are entitled to tender 1 for every 18 shares held.
Everyone else tenders in the general category. In either category you may tender more than your entitlement; extra shares are accepted only if other shareholders tender less than theirs.
Windlas Biotech Buyback Documents
- Post-offer announcement ↗May 2026
- SEBI filing ↗Apr 2026
- Letter of offer ↗Apr 2026
- Public announcement ↗Apr 2026
Other Open & Upcoming Buybacks
| Company | Buyback price | Record date | Status |
|---|---|---|---|
| Open · closes 23 Nov | Buyback price₹240 | Record date11 Nov 2026 | Open · closes 23 Nov |
| Awaiting tender dates | Buyback price₹500 | Record date13 Nov 2026 | Awaiting tender dates |
| Record date 20 Nov | Buyback price₹425 | Record date20 Nov 2026 | Record date 20 Nov |
| Record date 25 Nov | Buyback price₹91 | Record date25 Nov 2026 | Record date 25 Nov |
Windlas Biotech Buyback – FAQs
What is the Windlas Biotech buyback price?
₹1,000 per share. The buyback is worth up to ₹47 crore.
What is the record date of the Windlas Biotech buyback?
24 Apr 2026. Trades settle T+1, so shares have to be bought by 23 Apr 2026 to be in your demat account on the record date.
Who is a small shareholder in the Windlas Biotech buyback?
A shareholder whose Windlas Biotech shares are worth no more than ₹2 lakh at the closing price on the record date. Small shareholders tender in a reserved category with an entitlement of 1 for every 18 shares held.
What is the Windlas Biotech buyback ratio?
Small shareholders: 1 for every 18 shares held. This is the minimum accepted if you tender at least that many; extra shares tendered are accepted only if others tender less than their entitlement.
How to tender shares in the Windlas Biotech buyback?
Between 30 Apr 2026 and 7 May 2026, place a buyback (tender) order through your broker, usually under corporate actions or offers. The shares are blocked in your demat account; accepted shares are paid at the buyback price and the rest are released.
Is the Windlas Biotech buyback premium my profit?
Not all of it. Only the shares the company accepts are bought at ₹1,000; the rest come back to your demat account and are worth whatever the market pays when they return. Tax and brokerage also come out of the gain. In this buyback 48.55% of the shares small shareholders tendered were accepted.
How many shares were tendered in the Windlas Biotech buyback?
26,61,097 shares, 5.66 times the 4,70,000 shares on offer (as of 7 May 2026, 4:00 PM). If every bid stands, about 17.67% of all tendered shares can be bought; small shareholders, who have a separate reserve, usually get a different ratio.
How is the Windlas Biotech buyback taxed?
Only your gain (buyback price minus what you paid) is taxed, as a capital gain: 12.5% if you held the shares for more than 12 months (above the ₹1.25 lakh yearly exemption), 20% if you held them for 12 months or less. Promoters pay an additional tax.
Terms are read from the public announcement and letter of offer Windlas Biotech filed with SEBI and the stock exchanges; the letter of offer is the final word. IPO Guru is not a SEBI-registered research analyst — this page reports the offer terms and is not a recommendation to buy, hold or tender the shares. Tax figures are estimates for a resident individual who is not a promoter; check with your tax adviser.